Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2012
08/29/2012CN102648957A Traditional Chinese medicine for treating kidney disease and kidney deficiency
08/29/2012CN102648947A Medicinal milk liquor for treating prostatitis
08/29/2012CN102648931A Preparation method for rhododendron micranthum flavonoid extract
08/29/2012CN102302717B Traditional Chinese medicine composition and medical pad for treating prostatic disease, and preparation method of medical pad
08/29/2012CN102250189B Glycyrrhetic acid derivative with 1, 12-diene-3-ketone skeleton, its preparation method and medicinal uses
08/29/2012CN102038721B Pinus extract and application thereof
08/29/2012CN101756991B Sustained-release pills of alfuzosin hydrochloride
08/29/2012CN101108878B Glp-1 analogues
08/28/2012US8252929 8-carboxamido-2,6-methano-3-benzazocines
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252739 Albumin fusion proteins
08/28/2012CA2656079C Cyclic amine compound
08/28/2012CA2550441C Benzimidazole derivatives and medical uses thereof
08/23/2012WO2012112742A1 Substituted aminobutyric derivatives as neprilysin inhibitors
08/23/2012WO2012112426A1 Arginine vasopressin retargeted clostridial endopeptidases for use in treating benign prostatic hyperplasia
08/23/2012WO2012111643A1 Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
08/23/2012WO2012110625A1 Wild-type apolipoprotein l-i for use in the prevention of kidney diseases
08/23/2012WO2012110092A1 Tamsulosin derivatives
08/23/2012WO2012109975A1 Pegylated analogue protein of canine urate oxidase, preparation method and use thereof
08/23/2012US20120214858 Imidamide sphingosine kinase inhibitors
08/23/2012US20120214827 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/23/2012US20120214817 Urotensin ii receptor antagonists
08/23/2012US20120214814 Antioxidant inflammation modulators: oleanolic acid derivatives with amino acid and other modifications at c-17
08/23/2012US20120214787 Oxadiazole inhibitors of leukotriene production
08/23/2012US20120214771 Compositions for treatment of cardiometabolic disorders
08/23/2012US20120214760 Treatment of urinary tract infections with antibacterial aminoglycoside compounds
08/23/2012US20120214729 Composition for preventing or treating inflammation
08/23/2012US20120214687 Baff receptor (bcma), an immunoregulatory agent
08/23/2012US20120213853 Compositions and improved soft tissue replacement methods
08/23/2012US20120213852 Compositions and improved soft tissue replacement methods
08/23/2012US20120213800 Methods for treating and diagnosing disease
08/23/2012US20120213791 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
08/23/2012US20120213777 Vascular endothelial growth factor 2
08/23/2012US20120213775 Treatment of renal diseases
08/23/2012US20120213758 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/23/2012US20120213702 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13)
08/23/2012US20120213699 Single chain fragment of monoclonal antibody 9b9 and uses thereof
08/23/2012CA2827006A1 Wild-type apolipoprotein l-i for use in the prevention of kidney diseases
08/23/2012CA2825737A1 Substituted aminobutyric derivatives as neprilysin inhibitors
08/22/2012EP2489667A1 Quinoxaline derivative
08/22/2012EP2489666A2 Chemically and chirally pure solifenacin base and its salts
08/22/2012EP2489663A1 Compounds as syk kinase inhibitors
08/22/2012EP2489365A1 Wild-type apolipoprotein L-I for use in the prevention of kidney diseases
08/22/2012EP2488530A1 Spirocyclic piperidine derivatives useful as renin inhibitors
08/22/2012EP2183239B1 Sulfonamides as trpm8 modulators
08/22/2012EP2046775B1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
08/22/2012EP1507780B1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
08/22/2012EP1200431B3 Quinuclidine derivatives and their use as muscarinic m3 receptors ligands
08/22/2012CN102643818A Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases
08/22/2012CN102643333A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
08/22/2012CN102643256A Arylglucoside compound and preparation method and application thereof
08/22/2012CN102641502A Novel use of aromatase inhibitors
08/22/2012CN102641456A Traditional Chinese medicine mixture for treating pediatric membranous nephropathy
08/22/2012CN102641446A Chinese medicament for treating prostatic diseases and preparation method thereof
08/22/2012CN102641430A Traditional Chinese medicine decoction for treating diabetic nephropathy (DN)
08/22/2012CN102641402A Preparation and quality control method of traditional Chinese medicine compound preparation for treating nephritis
08/22/2012CN102641387A Method for supercritically extracting natural activity ingredient oil tea polyphenol from oil tea fruits
08/22/2012CN102641342A Traditional Chinese medicine extract for treating nephropathy and preparation method
08/22/2012CN102641341A Traditional Chinese medicine extract for treating nephropathy and preparation method thereof
08/22/2012CN102641340A Traditional Chinese medicine extract for treating nephropathy and preparation method
08/22/2012CN102641329A Formula for winter-summer combined treatment of post-urination drip and scrotal damp itching and preparation method
08/22/2012CN102641310A Khosam oil suppository
08/22/2012CN102641282A Compound erythromycin ethylsuccinate nano emulsion antibacterial agent and preparation method thereof
08/22/2012CN102641280A Pioglitazone hydrochloride and glimepiride combination medicine, tablet and application thereof
08/22/2012CN102641251A Underwater-dispersible tablet of Sevelamer carbonate
08/22/2012CN102220215B Health-care wine
08/22/2012CN102114046B Preparation method of oviductus ranae preparation
08/22/2012CN102101893B Method for enriching and purifying aloe polysaccharides in aloe
08/22/2012CN102091256B Specific medicinal liquor and preparation thereof for treating prostatitis and inflammations of genitourinary system
08/22/2012CN101897979B Targeted medicament for curing prostate diseases
08/22/2012CN101780070B Pharmaceutical composition for treating diabetic nephropathy and preparation method thereof
08/22/2012CN101780069B Drug composite for preventing diabetic nephropathy and preparation method thereof
08/22/2012CN101346346B Amine compound and use thereof for medical purposes
08/22/2012CN101167724B Application of medicinal composition containing amlodipine in preparing medicine for treating lower urinary tract disease
08/22/2012CN101088523B Nanometer solid lipid particle of active skullcap components and its prepn process and prepn
08/21/2012US8247415 Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists
08/21/2012US8247403 Benzoxazepine derivatives and use thereof
08/21/2012US8247376 NGAL for reduction and amelioration of ischemic and nephrotoxic injuries
08/21/2012US8246987 Controlled release composition and method of producing the same
08/21/2012CA2483848C Antibody against human insulin-like growth factor
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2371723C Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
08/16/2012WO2012109527A2 Class of hdac inhibitors expands the renal progenitor cells population and improves the rate of recovery from acute kidney injury
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012WO2011105099A8 Compound containing a novel 4-alkoxypyrimidine formation and medicine containing same
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120208887 Stable, liquid, ready-to-use ketoprofen formulations
08/16/2012US20120208850 Methods, compounds, and compositions for delivering 1,3-propanedisulfonic acid
08/16/2012US20120208831 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
08/16/2012US20120208830 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/16/2012US20120208829 2-phenoxy pyrimidinone analogues
08/16/2012US20120208822 Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor
08/16/2012US20120208808 Pyrazolopyrimidine derivatives
08/16/2012US20120208767 Method to Detect or Treat Painful Bladder Syndrome based on Relation to Quinone Oxidoreductase 1
08/16/2012US20120207773 Materials and methods for the development of an antigen-specific immune non-responsiveness state
08/16/2012US20120207729 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders
08/16/2012US20120207713 Probiotic bifidobacterium strains
08/15/2012EP2486937A1 Methods for treating a urethral stricture with a botulinum toxin
1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 562